PDF Cover

Blood Collection Devices Market

The market for Blood Collection Devices was estimated at $8.4 billion in 2024; it is anticipated to increase to $13.0 billion by 2030, with projections indicating growth to around $18.8 billion by 2035.

Report ID:DS1801615
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Blood Collection Devices
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Blood Collection Devices Market Outlook

Revenue, 2024

$8.4B

Forecast, 2034

$17.5B

CAGR, 2025 - 2034

7.6%

The Blood Collection Devices industry revenue is expected to be around $9.0 billion in 2025 and expected to showcase growth with 7.6% CAGR between 2025 and 2034. The increasing demand for accurate diagnostic testing and preventive healthcare services continues to strengthen the importance of blood collection devices across global healthcare systems. Rising prevalence of chronic diseases, expanding geriatric populations, and growing awareness regarding early disease detection are major factors supporting market expansion. Healthcare providers are increasingly adopting advanced blood collection technologies to improve patient safety, minimize contamination risks, and enhance laboratory efficiency. In addition, the expansion of diagnostic laboratories, blood banks, and home healthcare services is creating sustained demand for reliable specimen collection solutions. Continuous investments in healthcare infrastructure and infection prevention technologies are further contributing to the growing relevance of blood collection devices in modern clinical and diagnostic practices.

Blood Collection Devices include a wide range of medical tools designed for safe and efficient collection, storage, and transportation of blood samples for diagnostic, therapeutic, and research purposes. These devices primarily include needles, syringes, vacuum blood collection tubes, lancets, and advanced safety-engineered collection systems. Blood collection devices are extensively used in hospitals, diagnostic laboratories, blood banks, ambulatory surgical centers, and home healthcare settings for applications such as disease diagnosis, blood transfusion, routine health screening, and chronic disease monitoring. Recent trends driving market demand include increasing adoption of minimally invasive sampling technologies, growing preference for safety-engineered devices to reduce needle-stick injuries, and rising demand for point-of-care diagnostics. Technological advancements in automated blood collection systems and micro-sampling devices are also improving operational efficiency, patient comfort, and sample accuracy, supporting broader adoption across healthcare and clinical research industries globally.

Blood Collection Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Blood Collection Devices Market Outlook

Market Key Insights

  • The Blood Collection Devices market is projected to grow from $8.4 billion in 2024 to $17.5 billion in 2034. This represents a CAGR of 7.6%, reflecting rising demand across Hospitals, Ambulatory Surgical Centers, and Nursing Homes.

  • BD, Terumo BCT Inc., Fresenius Kabi AG are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Germany are the top markets within the Blood Collection Devices market and are expected to observe the growth CAGR of 4.9% to 7.3% between 2024 and 2030.

  • Emerging markets including Brazil, Indonesia and South Africa are expected to observe highest growth with CAGR ranging between 8.7% to 10.5%.

  • Transition like Transition from conventional blood sampling toward safety-engineered collection technologies is expected to add $1 billion to the Blood Collection Devices market growth by 2030.

  • The Blood Collection Devices market is set to add $9.1 billion between 2024 and 2034, with manufacturer targeting Therapeutic Applications Application projected to gain a larger market share.

  • With

    rising prevalence of infectious diseases and advancements in blood collection technologies, and

    Increasing Demand for Safe and Sterile Medical Procedures, Blood Collection Devices market to expand 108% between 2024 and 2034.

blood collection devices market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Blood Collection Devices - Country Share Analysis

Opportunities in the Blood Collection Devices

The rapid expansion of home healthcare services is also creating major opportunities for Blood Collection Devices manufacturers specializing in minimally invasive sampling technologies. Increasing elderly populations and growing preference for remote patient monitoring are driving demand for lancets, capillary blood collection systems, and micro-sampling devices suitable for home-based diagnostics. Technological advancements enabling easier self-collection and improved sample accuracy are strengthening adoption among chronic disease patients requiring routine testing. North America and Europe are expected to witness the fastest growth because of advanced telehealth infrastructure and rising consumer preference for convenient healthcare solutions that reduce hospital visits and improve long-term disease management efficiency.

Growth Opportunities in North America and Asia Pacific

The blood collection device market in North America benefits from its well developed healthcare system and elevated healthcare spending levels. The market competition in North America remains intense because BD and Terumo BCT Inc. maintain their dominant positions in the region. The rising number of medical conditions that need blood tests and rising surgical procedures create substantial market demand for blood collection devices in this region. The market will experience its most significant expansion through automated blood collection technology development and process automation integration.
The Asia Pacific blood collection devices market experiences fast expansion because China and India along with other emerging nations drive its growth. The market competition becomes more intense because Fresenius Kabi AG and Nipro Corporation operate alongside local manufacturers. The region experiences market growth because of its expanding population and rising blood donation awareness and increasing disease prevalence. The region presents opportunities for market growth because healthcare infrastructure investments continue to rise and people need better and more efficient blood collection systems.

Market Dynamics and Supply Chain

01

Driver: Rising chronic disease prevalence and expanding diagnostic laboratory infrastructure worldwide

The increasing prevalence of chronic diseases and the rapid expansion of diagnostic laboratory infrastructure are also major drivers accelerating demand for Blood Collection Devices globally. Growing cases of diabetes, cardiovascular disorders, cancer, and infectious diseases are also increasing the need for routine blood testing and long-term patient monitoring. This trend is also significantly boosting demand for reliable blood collection tubes, safety needles, and vacuum-assisted sampling systems across hospitals and laboratories. Simultaneously, healthcare providers are also investing heavily in advanced diagnostic laboratories equipped with automated testing technologies to improve testing efficiency and diagnostic accuracy. Expanding laboratory networks in emerging economies and rising adoption of preventive healthcare practices are also further supporting market growth. Technological advancements in sample handling, contamination prevention, and automated specimen management systems continue strengthening the commercial relevance of modern blood collection devices.
The growing emphasis on healthcare worker safety and infection prevention is also strongly driving adoption of safety-engineered blood collection devices across healthcare facilities. Hospitals, diagnostic laboratories, and outpatient care centers are also increasingly utilizing retractable needles, closed blood collection systems, and needle-stick prevention technologies to reduce occupational exposure to bloodborne infections. Regulatory agencies and healthcare organizations are also also implementing stricter workplace safety guidelines encouraging the use of advanced collection systems with improved protective mechanisms. In addition, rising awareness regarding contamination control and patient safety is also accelerating replacement of conventional blood collection tools with technologically advanced alternatives. Continuous innovation in minimally invasive sampling devices and ergonomic collection equipment is also further supporting industry expansion across clinical and diagnostic healthcare environments.
02

Restraint: Stringent regulatory compliance requirements and rising safety concerns increase operational manufacturing burdens

The Blood Collection Devices market faces significant restraints due to strict regulatory compliance standards and ongoing healthcare worker safety concerns. Manufacturers must comply with complex sterilization, labeling, and quality validation requirements imposed by agencies such as the FDA and EU MDR, increasing development costs and delaying product approvals. At the same time, needle-stick injuries and contamination risks continue pressuring healthcare providers to adopt advanced safety-engineered devices, which are substantially more expensive than conventional alternatives. For example, smaller healthcare facilities in emerging markets often delay upgrades because of budget limitations, reducing demand for premium products. These regulatory and safety-related burdens collectively limit profit margins, slow innovation cycles, and create entry barriers for new manufacturers.
03

Opportunity: Increasing pediatric diagnostic testing drives innovation in low-volume blood collection technologies and Rising point-of-care testing adoption strengthens opportunities across emergency healthcare facilities

The growing focus on pediatric healthcare is generating new opportunities for blood collection device manufacturers developing low-volume and patient-friendly sampling systems. Pediatric hospitals and neonatal care units increasingly prefer micro-collection tubes, heel lancets, and capillary blood sampling devices designed to minimize discomfort and reduce blood loss during diagnostic testing. Rising awareness regarding child-focused healthcare practices and advancements in micro-sampling technologies are supporting broader adoption across specialty healthcare facilities. Europe and North America are expected to lead growth due to strong pediatric healthcare infrastructure and increasing investment in advanced neonatal care services. Manufacturers emphasizing ergonomic designs and minimally invasive technologies are gaining competitive advantages in this rapidly evolving segment.
Growing utilization of point-of-care diagnostics in emergency rooms, ambulatory care centers, and critical care units is creating significant growth opportunities for advanced blood collection devices. Healthcare providers increasingly require rapid and contamination-free sample collection systems capable of supporting immediate diagnostic decision-making. Vacuum blood collection tubes, safety needles, and portable micro-collection devices are expected to experience strong demand growth due to their compatibility with fast diagnostic workflows. Strategic collaborations between diagnostic companies and device manufacturers are accelerating innovation in compact and user-friendly collection systems. Asia-Pacific is emerging as a high-potential region because expanding healthcare infrastructure and rising emergency care investments are increasing demand for rapid diagnostic technologies.
04

Challenge: High costs of advanced collection systems reduce adoption across developing healthcare markets

The high cost of automated and safety-engineered blood collection systems remains a major restraint limiting market penetration in price-sensitive healthcare environments. Advanced vacuum-assisted systems, retractable safety needles, and automated blood collection platforms require higher procurement and maintenance investments, making them less accessible for rural hospitals and low-income healthcare providers. For instance, many developing healthcare systems continue relying on conventional manual collection devices because advanced alternatives significantly increase operational expenses. In addition, supply chain disruptions involving plastics, stainless steel, and sterilization materials have raised manufacturing and distribution costs, further increasing product prices. These pricing pressures reduce purchasing flexibility for hospitals and diagnostic laboratories, ultimately slowing adoption of technologically advanced blood collection devices across emerging global markets.

Supply Chain Landscape

1

Components & Sub-Assembly

Nipro CorporationSarstedt
2

Device Manufacturing

BDTerumo BCT Inc
3

Distribution & Logistics

McKessonCardinal Health
4

End User

HospitalsDiagnostic CentersBlood Banks
Blood Collection Devices - Supply Chain

Use Cases of Blood Collection Devices in Hospitals & Nursing Homes

Hospitals : Hospitals represent the largest application segment for Blood Collection Devices due to the high volume of diagnostic testing, emergency care procedures, and surgical treatments performed daily. Vacuum blood collection systems, safety needles, syringes, and blood collection tubes are the most commonly used devices in hospital settings because they ensure accurate sample collection while minimizing contamination and needle-stick injuries. Hospitals rely heavily on these devices for routine blood tests, transfusion procedures, chronic disease monitoring, and preoperative diagnostics. Their advantages include improved workflow efficiency, enhanced patient safety, and compatibility with automated laboratory systems. Rising hospital admissions and increasing demand for rapid diagnostic testing continue to support strong adoption across modern healthcare facilities globally.
Ambulatory Surgical Centers : Ambulatory surgical centers are increasingly utilizing advanced blood collection devices to support outpatient surgeries, preoperative screening, and post-procedure monitoring. Safety-engineered lancets, vacuum blood collection tubes, and winged blood collection sets are commonly preferred in these facilities because they enable quick, minimally invasive, and efficient sample collection within fast-paced clinical environments. These devices help ambulatory centers maintain operational efficiency while reducing patient waiting times and infection risks. The growing preference for same-day surgical procedures and minimally invasive treatments is significantly driving demand for compact and easy-to-use blood collection technologies. In addition, ambulatory surgical centers benefit from devices that improve sample accuracy and simplify integration with diagnostic laboratories for timely clinical decision-making and patient management.
Nursing Homes : Nursing homes are becoming important end users of blood collection devices due to the increasing elderly population requiring continuous health monitoring and chronic disease management. Capillary blood collection devices, lancets, and safety syringes are widely used in these facilities because they support convenient blood sampling for patients with limited mobility and age-related health complications. These devices are primarily utilized for diabetes management, infection monitoring, routine laboratory testing, and medication assessment among long-term care residents. Their advantages include reduced patient discomfort, ease of handling for caregivers, and improved infection control. Rising focus on geriatric healthcare services and preventive disease management is encouraging nursing homes to adopt safer and more patient-friendly blood collection technologies across long-term care environments.

Impact of Industry Transitions on the Blood Collection Devices Market

As a core segment of the Medical Device industry, the Blood Collection Devices market develops in line with broader industry shifts. Over recent years, transitions such as Transition from conventional blood sampling toward safety-engineered collection technologies and Shift from centralized laboratory testing toward decentralized point-of-care diagnostic collection systems have redefined priorities across the Medical Device sector, influencing how the Blood Collection Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Transition from conventional blood sampling toward safety-engineered collection technologies

The blood collection devices industry is rapidly transitioning from conventional sampling equipment to safety-engineered collection technologies designed to minimize contamination and needle-stick injuries. Hospitals, diagnostic laboratories, and outpatient care centers are increasingly adopting retractable needles, closed vacuum systems, and automated collection devices to improve healthcare worker safety and regulatory compliance. This transition is significantly impacting the healthcare and medical manufacturing industries, where companies are investing in advanced infection-prevention technologies and ergonomic device designs. For example, diagnostic laboratories are replacing traditional syringes with vacuum-assisted blood collection systems to improve specimen quality, reduce handling errors, and streamline automated laboratory testing workflows across high-volume clinical environments.
02

Shift from centralized laboratory testing toward decentralized point-of-care diagnostic collection systems

The blood collection devices market is witnessing a major shift from centralized laboratory-based testing toward decentralized point-of-care and home-based diagnostic systems. Rising demand for rapid diagnostics, remote patient monitoring, and home healthcare services is accelerating adoption of portable blood collection devices and minimally invasive micro-sampling technologies. This transition is influencing telehealth, diagnostic services, and home healthcare industries by encouraging development of user-friendly self-collection solutions. For instance, chronic disease management programs increasingly utilize capillary blood collection kits for home monitoring of glucose levels and infectious disease testing. The trend is also driving collaborations between diagnostic companies and digital healthcare providers to improve accessibility, patient convenience, and faster clinical decision-making.